Latest news and press releases about SI-BONE, Inc. (SIBN): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally.
Price
| Price | $18.54 |
| Market Cap | $822M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 4.50 |
| EV / EBITDA | -158.17 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -8.23% |
| Return on Invested Capital | -7.88% |
| Return on Assets | -5.88% |
| Gross Margin | 79.53% |
| Operating Margin | -8.31% |
| Net Margin | -6.85% |
Related companies: AIRS · AQST · AVNS · AVXL · BFLY · CLPT · INNV
Explore sector: Healthcare · Medical - Devices
More sections of SIBN: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks